Rosetta Genomics Pays Off Secured Loan and Reclaims Unencumbered Rights to All Assets
PHILADELPHIA and REHOVOT, Israel, June 22, 2012 /PRNewswire/ -- Rosetta Genomics , a leading developer and provider of microRNA-based molecular diagnostic assays, today announced that the Company has entered into an agreement and release with the holders of the $1,750,000 senior secured debenture the Company sold and issued on January 27, 2012.
Join the discussion below, or Read more at Freshnews.
#1 Jun 26, 2012
Is ROSG more than doubling in its value soon?
Check the full article here:
Add your comments below
|Mesothelioma Lawyer Johnson Still Worries About... (Aug '07)||Mar '15||mikya123||7|
|Asbestos diseases cripple SA mining towns (Feb '08)||Feb '15||maxwellaj||10|
|YouDocs: Managing your cancer treatment||Dec '14||maryjaneprincton||1|
|Childhood exposure to Libby amphibole during ou...||Dec '14||The Hat||2|
|Asbestos (Jan '11)||Oct '14||kurtcooksalot16||3|
|Asbestos pushed in Asia as product for the poor (Aug '14)||Aug '14||A Teacher||5|
|Lawyers (Aug '14)||Aug '14||tired of not knowing||2|
Find what you want!
Search Mesothelioma Forum Now
Copyright © 2015 Topix LLC